![](https://webarchive.library.unt.edu/eot2008/20090514033044im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514033044im_/http://www.cancer.gov/images/spacer.gif)
| A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the anticancer drug PEG-asparaginase that stays in the body longer. EZN-2285 is an enzyme that breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. It is a type of protein synthesis inhibitor. Also called Oncaspar-IV and SC-PEG E. coli L-asparaginase. |
Previous Definitions: | extraocular, extraosseous, extrapleural pneumonectomy, extravasation, eye cancer | Next Definitions: | F-18 16 alpha-fluoroestradiol, F-18 FES, falimarev, fallopian tube, false-negative test result |
|
![](https://webarchive.library.unt.edu/eot2008/20090514033044im_/http://www.cancer.gov/images/spacer.gif) |